Company profilePharmaceutical#106 of 1,318 in Pakistan1 DRAP alert

SURGE LABORATORIES (PVT) LTD.

Pharmaceutical company · 151 brands · 166 molecules

Ranked #36 of 213 companies in Other Beta-Lactam, Cephalosporins & Penems

151 registered products 52 pharmaceutical brands 166 distinct molecules 1 DRAP alert

Company overview

151
registered products
52
pharmaceutical brands
166
distinct molecules
12
therapeutic classes
1
DRAP alerts

SURGE LABORATORIES (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 151 product registrations across 166 distinct molecules. It is the 106th largest registrant in Pakistan by product count, and ranks 36th of 213 in Other Beta-Lactam, Cephalosporins & Penems. Its portfolio is concentrated in Other Beta-Lactam, Cephalosporins & Penems and Antimalarials. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by SURGE

91 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

87
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202687

Top molecules by brand count

Artemether6 brands
Bupivacaine5 brands
Risperidone5 brands
Cefixime5 brands
Lumefantrine4 brands
Ceftazidime4 brands
Artesunate4 brands
Ceftriaxone3 brands

Therapeutic classes

Other Beta-Lactam, Cephalosporins & Penems · 7Antimalarials · 4Muscle Relaxant · 3Aminoglycoside Antibacterials · 2Other Anti-Baterials · 2Vitamin A, D & Combinations · 2Anaesthetic, Local · 2Other Analgesics And Antipyretics · 2Antispasmodic & Anticholinergic · 2Quinolone Antibacterials · 2Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 2Antiemetics & Antinauseants · 2

Conditions treated

Anaemia · 1Schizophrenia/Psychosis · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official157 products · Rs 4.8 – Rs 30,876.73
DVAGO4 products · Rs 250 – Rs 1,239.75
Servaid2 products · Rs 695.1 – Rs 1,250
Median across source: Rs 512.55

Regulatory record

1 alert in the DRAP feed we track.

Recall Alert: Drug Product; Calcium Gluconate Injection (Batch # 220325) by M/s Shaheen Ag
2023-02-28

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 117 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherAscorbic AcidAtorvastatin
NEUTRO PHARMA (PVT) LTD. holds 104 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAnastrazoleAnastrozoleAntimony
AKSON PHARMACEUTICALS (PVT) LTD. holds 36 molecules not in this portfolio
000 I.UAzithromycinCefotaxime SodiumChloroquineCiprofloxacinClarithromycin

Get the full profile for SURGE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.